PPT-Orphan Drug Global Incentives & Regulatory Framework

Marlene E Haffner MD MPH CEO Haffner Associates LLC Orphan Drugs Summit 2012 Thursday 27 th September 2012 Current Pharma Trends Slow pharma industry growth Patent

drug orphan disease approval orphan drug approval disease products development rare product designation regulatory population prevalence threatening clinical amp

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/731435" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "Orphan Drug Global Incentives & Regu..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.